Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Neurology
•
Neuro-immunology
What is your preferred first line therapy for patients with MOG-associated disease and multiple relapses?
Related Questions
How do you use optical coherence tomography in the diagnosis and management of patients with multiple sclerosis and related diseases?
If a patient with relapsing remitting MS has comorbid Sjogren's syndrome and is on hydroxychloroquine (Plaquenil), how does that impact choice of DMT for MS?
How do you interpret the results of oligoclonal bands ordered to evaluate for demyelinating disease in patients with brain MRI lesions of unclear etiology?
What is your treatment approach to neurological Sjogrens disease with both peripheral neuropathy and transverse myelitis?
What lab levels would lead you to consider switching DMTs for patients with MS on Fingolimod?
If a patient develops itching with their first dose of Tysabri despite pre-treatment, does this indicate that further cycles of Tysabri are contraindicated or do you continue Tysabri at the next cycle?
What do you consider when deciding to use a high-efficacy DMT as an initial treatment in multiple sclerosis?
Do you send CSF or serum ACE levels in the workup of neurosarcoidosis?
Do you see a current or future clinical role of neurofilament light chain in the diagnosis or workup of multiple sclerosis?
How do you decide between escalation to a high efficacy DMT versus switching to a different moderate efficacy DMT in patients with poorly controlled multiple sclerosis?
